Podcast


Presenter: Dr. James McCormack Dr. Jennifer Young Dr. Michael Allan

In episode 601, James and Mike invite Jennifer Young back to the podcast to go over all the evidence we have for pregabalin and gabapentin in patients with fibromyalgia. During the discussion we find out how many people actually get a ≥30% reduction in pain compared to placebo. We even look at some information about…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

CFP Podcast: Anaplasmosis: An emerging threat in Canada

With climate change the distribution of ticks is extending throughout Canada and along with that the increasing risk of tick-borne infectious diseases. Join CFP Editor Dr. Nick Pimlott and Associate…
Listen 0.5 credits available

Pharmascope Épisode 103: La vitamine B12, la nouvelle vitamine D? – partie 2

Un nouvel épisode du pharmascope est maintenant disponible! Dans de ce 103ème épisode, Nicolas, Sébastien et Isabelle discutent encore une fois de vitamine B12. Cette fois, on jase de plein…
Listen 0.5 credits available

Pharmascope Épisode 102: La vitamine B12, la nouvelle vitamine D?

Un nouvel épisode du pharmascope est maintenant disponible! Dans de ce 102ème épisode, Nicolas, Sébastien et Isabelle discuteront de vitamine B12. Dans ce premier épisode d’une série de deux, on…
Listen 0.5 credits available

Presenter(s):

Dr. James McCormack Dr. Jennifer Young Dr. Michael Allan

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Dr. James McCormack
  • Dr. Jennifer Young
  • Dr. Michael Allan

Spearkers do not have any conflicts of interest to declare.